Baharak Moshiree

Baharak Moshiree

Auto-generated profile, based on publicly available information

Baharak Moshiree

Atrium Health Wake Forest Baptist Morehead Medical Plaza Charlotte North Carolina USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Gastroenterology
Verified
Journal Article
Open access
BMBaha Moshiree
Baha Moshiree
DDDouglas Drossman
Douglas Drossman
ASAasma Shaukat
Aasma Shaukat
Belching, bloating, and abdominal distention are all highly prevalent gastrointestinal symptoms and account for some of the most common reasons for patient visits to outpatient gastroenterology practices. These symptoms are often debilitating, affecting patients' quality of life, and contributing to work absenteeism. Belching and bloating differ in their pathophysiology, diagnosis, and management, and there is limited evidence available for their various treatments. Therefore, the purpose of this American Gastroenterological Association (AGA) Clinical Practice Update is to provide best practice advice based on both controlled trials and observational data for clinicians covering clinical features, diagnostics, and management considerations that include dietary, gut-directed behavioral, and drug therapies. This Expert Review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. These best practice advice statements were drawn from a review of the published literature based on clinical trials, the more robust observational studies, and from expert opinion. Because systematic reviews were not performed, these best practice advice statements do not carry formal ratings regarding the quality of evidence or strength of the presented considerations. Best Practice Advice Statements BEST PRACTICE ADVICE 1: Clinical history and physical examination findings and impedance pH monitoring can help to differentiate between gastric and supragastric belching. BEST PRACTICE ADVICE 2: Treatment options for supragastric belching may include brain-gut behavioral therapies, either separately or in combination, such as cognitive behavioral therapy, diaphragmatic breathing, speech therapy, and central neuromodulators. BEST PRACTICE ADVICE 3: Rome IV criteria should be used to diagnose primary abdominal bloating and distention. BEST PRACTICE ADVICE 4: Carbohydrate enzyme deficiencies may be ruled out with dietary restriction and/or breath testing. In a small subset of at-risk patients, small bowel aspiration and glucose- or lactulose-based hydrogen breath testing may be used to evaluate for small intestinal bacterial overgrowth. BEST PRACTICE ADVICE 5: Serologic testing may rule out celiac disease in patients with bloating and, if serologies are positive, a small bowel biopsy should be done to confirm the diagnosis. A gastroenterology dietitian should be part of the multidisciplinary approach to care for patients with celiac disease and nonceliac gluten sensitivity. BEST PRACTICE ADVICE 6: Abdominal imaging and upper endoscopy should be ordered in patients with alarm features, recent worsening symptoms, or an abnormal physical examination only. BEST PRACTICE ADVICE 7: Gastric emptying studies should not be ordered routinely for bloating and distention, but may be considered if nausea and vomiting are present. Whole gut motility and radiopaque transit studies should not be ordered unless other additional and treatment-refractory lower gastrointestinal symptoms exist to warrant testing for neuromyopathic disorders. BEST PRACTICE ADVICE 8: In patients with abdominal bloating and distention thought to be related to constipation or difficult evacuation, anorectal physiology testing is suggested to rule out a pelvic floor disorder. BEST PRACTICE ADVICE 9: When dietary modifications are needed (eg, low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet), a gastroenterology dietitian should preferably monitor treatment. BEST PRACTICE ADVICE 10: Probiotics should not be used to treat abdominal bloating and distention. BEST PRACTICE ADVICE 11: Biofeedback therapy may be effective for bloating and distention when a pelvic floor disorder is identified. BEST PRACTICE ADVICE 12: Central neuromodulators (eg, antidepressants) are used to treat bloating and abdominal distention by reducing visceral hypersensitivity, raising sensation threshold, and improving psychological comorbidities. BEST PRACTICE ADVICE 13: Medications used to treat constipation should be considered for treating bloating if constipation symptoms are present. BEST PRACTICE ADVICE 14: Psychological therapies, such as hypnotherapy, cognitive behavioral therapy, and other brain-gut behavior therapies may be used to treat patients with bloating and distention. BEST PRACTICE 15: Diaphragmatic breathing and central neuromodulators are used to treat abdominophrenic dyssynergia.

1 January 2019 in Gastrointestinal Endoscopy Clinics of North America
Verified
Journal Article
Closed access
BMBaha Moshiree
Baha Moshiree
MPMichael Potter
Michael Potter
NTNicholas J. Talley
Nicholas J. Talley

29 October 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
BMBaha Moshiree
Baha Moshiree
AFAlvin Jay Freeman
Alvin Jay Freeman
PVPhuong T. Vu
Phuong T. Vu
UKUmer Khan
Umer Khan
CUCarmen Ufret-Vincenty
Carmen Ufret-Vincenty
MSMeghana Nitin Sathe
Meghana Nitin Sathe

6 September 2019 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SKSu Bin Kim
Su Bin Kim
FCFernando H. Calmet
Fernando H. Calmet
JGJose Garrido
Jose Garrido
MGMonica T. Garcia-Buitrago
Monica T. Garcia-Buitrago
BMBaharak Moshiree
Baharak Moshiree

22 July 2022 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
BMBaha Moshiree
Baha Moshiree
JHJoel J. Heidelbaugh
Joel J. Heidelbaugh
GSGregory S. Sayuk
Gregory S. Sayuk
Irritable bowel syndrome with diarrhea (IBS-D) is a chronic disorder of gut–brain interaction, characterized by recurrent abdominal pain in association with more frequent, loose stools. The pathophysiology of irritable bowel syndrome (IBS) includes disordered gut motility, alterations in gut microbiota, neural-hormonal system abnormalities, immune reactivity, and visceral hypersensitivity. Timely diagnosis of IBS-D can be achieved easily using clinical criteria. Formal IBS diagnosis is important for optimizing treatment and patient outcomes and facilitating patient access to appropriate educational resources. Yet, given the symptom overlap with other gastrointestinal conditions, diagnosis of IBS-D often is perceived to be challenging. Treatment of IBS includes both nonpharmacologic and pharmacologic options. Rifaximin, alosetron, and eluxadoline are effective treatments indicated for IBS-D, but have limited availability internationally. Dietary approaches may also be indicated for certain patients with IBS-D. Psychological interventions may be effective in treating abdominal pain alone and global symptoms in IBS. We describe use of these diverse therapies and provide an overview to facilitate the primary care provider’s approach to distinguishing IBS-D from other conditions with symptom overlap.

22 July 2021 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
MSMeghana Nitin Sathe
Meghana Nitin Sathe
BMBaha Moshiree
Baha Moshiree
PVPhuong T. Vu
Phuong T. Vu
UKUmer Khan
Umer Khan
SHSonya L. Heltshe
Sonya L. Heltshe
AFA. Jay Freeman
A. Jay Freeman